Allspring Global Investments Holdings, LLC Ngm Biopharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$1.05 - $3.37 $17,291 - $55,497
16,468 New
16,468 $17,000
Q2 2023

Jul 18, 2023
BUY
$2.44 - $4.53 $18,946 - $35,175
7,765 New
7,765 $20,000
Q2 2022

Jul 25, 2022
SELL
$10.58 - $17.5 $94,288 - $155,960
-8,912 Reduced 94.0%
569 $7,000
Q1 2022

May 02, 2022
BUY
$13.81 - $18.6 $12,967 - $17,465
939 Added 10.99%
9,481 $144,000
Q4 2021

Jan 28, 2022
BUY
$17.26 - $22.02 $147,434 - $188,094
8,542 New
8,542 $151,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email